Resources from the same session
The nationwide cohort of 26,883 patients with sarcomas treated in NETSARC reference network between 2010 and 2015 in France: major impact of multidisciplinary board presentation prior to 1st treatment
Presenter: Jean-Yves Blay
Session: Sarcoma
Resources:
Abstract
Presentation
Webcast
Subgroup analysis of leiomyosarcoma (LMS) patients (pts) from a phase 3, open-label, randomized study of eribulin (ERI) versus dacarbazine (DTIC) in pts with advanced liposarcoma (LPS) and LMS
Presenter: Jean-Yves Blay
Session: Sarcoma
Resources:
Abstract
Results of a prospective randomized phase III T-SAR trial comparing trabectedin vs best supportive care (BSC) in patients with pretreated advanced soft tissue sarcoma (ASTS)
Presenter: Axel Le Cesne
Session: Sarcoma
Resources:
Abstract
Presentation
Webcast
Regorafenib (R) versus placebo (P) in soft tissue sarcomas (STS): analysis of genetic prognostic and predictive factors
Presenter: Thomas Brodowicz
Session: Sarcoma
Resources:
Abstract
Randomized phase 3, multicenter, open-label study comparing evofosfamide (Evo) in combination with doxorubicin (D) vs. D alone in patients (pts) with advanced soft tissue sarcoma (STS): Study TH-CR-406/SARC021
Presenter: William Tap
Session: Sarcoma
Resources:
Abstract
Presentation
Webcast
PD1 and PDL1 expression, tumoral microenvironment (TME) characterization and clinical implication in localized osteosarcoma
Presenter: Emanuela Palmerini
Session: Sarcoma
Resources:
Abstract
Optimizing the dose in cancer patients treated with imatinib, sunitinib and pazopanib
Presenter: Nienke Lankheet
Session: Sarcoma
Resources:
Abstract
Invited discussant abstracts 1403PD, 1404PD and 1405PD
Presenter: Silvia Stacchiotti
Session: Sarcoma
Resources:
Presentation
Webcast
Invited discussant abstracts 1401PD and 1402PD
Presenter: Xavier Garcia del Muro
Session: Sarcoma
Resources:
Presentation
Webcast
Exposure-response of olaratumab for survival outcomes and safety when combined with doxorubicin in soft tissue sarcoma (STS) patients
Presenter: Robin Jones
Session: Sarcoma
Resources:
Abstract